Quick Overview: Dr. Peter Block and Dr. Craig Smith discuss the Dr Michael J Mack (Baylor Scott & White Heart Hospital, Plano, TX, US) discusses the two-year clinical and echocardiographic ... Dr. Robert A. Guyton offers perspectives on the

Partner Trial Treatment For Severe - Detailed Overview & Context

Dr. Peter Block and Dr. Craig Smith discuss the Dr Michael J Mack (Baylor Scott & White Heart Hospital, Plano, TX, US) discusses the two-year clinical and echocardiographic ... Dr. Robert A. Guyton offers perspectives on the NEW ORLEANS -- High-risk patients who underwent transcatheter aortic valve replacement had the same survival at one year as ... TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) compared to surgical ... Dr. Lars Svensson, Chairman of the Heart and Vascular Institute and Dr. Samir Kapadia, Section Head, Interventional Cardiology ...

In this short virtual interview, we are joined by Dr Martin B Leon (Columbia University Medical Center, US) to discuss the 5-year ... Martin Leon, MD and Michael Mack, MD provide an overview of the results of Dr Michael Mack (Baylor Scott & White Heart Hospital, Plano, US) joins us to share the clinical and echocardiographic outcomes ... There is a desperate need for rapid turnaround of transplant clinical

Photo Gallery

PARTNER Trial - Treatment for Severe Aortic Stenosis
ACC.13 | PARTNER Trial Three-Year Outcomes
ACC.14 | TAVR vs. SAVR:  Is There a Diabetes Paradox?
PARTNER Trial
TCT 2010 | PARTNER Trial
ACC 2020: Updates from the PARTNER 3 Trial — Dr Michael J Mack
PARTNER Trial and Aortic Valve Replacement
PARTNER Finds TAVI as Good as Surgery
TCT 24: Pooled Analysis of RHEIA and PARTNER 3
PARTNER Trial at Scientific Sessions 2011
PARTNER 3: Lessons learned and impact on future patient care
PARTNER Trial Analysis
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored